Multiple Sclerosis Clinical Trial

Assessment of tDCS-Induced Neuronal Responses in Multiple Sclerosis (MS) With Advanced MRI

Summary

The objective of this trial is to measure the changes in neural activities during tDCS session using Magnetic Resonance Imaging (MRI). Participants (N=60) (20 Healthy Controls and 40 participants with neurological disorders, ie. multiple sclerosis) will be recruited to complete self-report measures and a brief cognitive assessment and then undergo an hour long stand-alone MRI scan while simultaneously undergoing tDCS stimulation. Methodology for this study is the administration of 15-minutes of of active tDCS during MRI acquisition compared to time without active tDCS.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Standardized SDMT Z-scores ≥3 standard deviations below mean
Able to understand all study instructions and supply written consent

Exclusion Criteria:

Extreme claustrophobia
History of mental retardation, pervasive developmental disorder or other neurological condition associated with cognitive impairment
Primary psychiatric disorder that would influence ability to participate
History of seizures or seizure disorder
History of head trauma in the past year (e.g., head injury, brain surgery) or medical device implanted in the head (such as Deep Brain Stimulator) or in the neck (such as a Vagus Nerve Stimulator)
Any skin disorder/sensitive skin (e.g., eczema, severe rashes), blisters, open wounds, burn including sunburns, cuts or irritation, or other skin defects which compromise the integrity of the skin at or near stimulation locations (where electrodes are placed)
Treatment for a communicable skin disorder currently or over the past 12 months
History of uncontrolled or labile hypertension.
Have any irremovable piercings, implantations or metallic-based tattoos
History of clinically significant abnormalities on electrocardiogram (EKG)
Pregnant or breastfeeding
Current substance abuse disorder

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

72

Study ID:

NCT03564496

Recruitment Status:

Completed

Sponsor:

NYU Langone Health

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

New York University School of Medicine
New York New York, 10016, United States

How clear is this clinincal trial information?

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

72

Study ID:

NCT03564496

Recruitment Status:

Completed

Sponsor:


NYU Langone Health

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.